Bck Partners, Inc. Johnson & Johnson Transaction History

Bck Partners, Inc.

$210 Million
Q3 2024

A detailed history of Bck Partners, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Bck Partners, Inc. holds 3,492 shares of JNJ stock, worth $541,294. This represents 0.27% of its overall portfolio holdings.

Number of Shares

3,492

Previous 3,529 1.05%

Holding current value

$541,294

Previous $515,000 9.71%

% of portfolio

0.27%

Previous 0.27%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$145.48 - $167.38 $5,382 - $6,193	-37 Reduced 1.05%	3,492 $565,000
Q2 2024 Jul 24, 2024	SELL	$144.38 - $157.78 $33,784 - $36,920	-234 Reduced 6.22%	3,529 $515,000
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $40,667 - $42,637	262 Added 7.48%	3,763 $595,000
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $58,717 - $65,778	377 Added 12.07%	3,501 $545,000
Q2 2023 Jul 20, 2023	SELL	$154.35 - $166.11 $80,262 - $86,377	-520 Reduced 14.27%	3,124 $517,000
Q4 2022 Jan 20, 2023	SELL	$160.2 - $179.79 $60,715 - $68,140	-379 Reduced 9.42%	3,644 $0
Q3 2022 Nov 07, 2022	BUY	$161.33 - $179.52 $2,581 - $2,872	16 Added 0.4%	4,023 $657,000
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $5,045 - $5,580	-30 Reduced 0.74%	4,007 $711,000
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $1.79 Million - $2.03 Million	-11,316 Reduced 73.71%	4,037 $715,000
Q1 2022 Apr 21, 2022	BUY	$158.14 - $179.59 $1.79 Million - $2.03 Million	11,316 Added 280.31%	15,353 $2.72 Million
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $2,027 - $2,249	-13 Reduced 0.32%	4,037 $691,000
Q1 2021 Apr 28, 2021	SELL	$153.07 - $170.48 $22,960 - $25,572	-150 Reduced 3.57%	4,050 $675,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $575,862 - $660,996	4,200 New	4,200 $661,000

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bck Partners, Inc. with notifications on news.

Account